Skip to main content
. 2021 Dec 1;42(5):746–756. doi: 10.1177/0271678X211063802

Table 2.

Clinical outcomes.

Derivation cohort

(n = 1005)

Validation cohort(n = 752)

Cerebral infarction, n (%) 79 (7.9) 50 (6.6)
Transient ischemic attack, n (%) 4 (0.4) 4 (0.5)
Systemic thromboembolism, n (%) 7 (0.7) 1 (0.1)
Mortality, n (%) 209 (20.8) 110 (14.6)